Pneumologische Praxis und Schlaflabor Lutz Volgmann und Kollegen
- Address
- Kopernikusstr. 5, 30167 Hanover, Germany
Pneumologische Praxis und Schlaflabor Lutz Volgmann und Kollegen
This specialized pulmonology practice and sleep laboratory focuses on advanced respiratory medicine and sleep disorders. The center demonstrates particular expertise in investigating novel therapeutic approaches for patients with chronic lung conditions, contributing to the development of innovative treatment strategies in respiratory care.
- Chronic Obstructive Pulmonary Disease (COPD) research and advanced triple therapy combinations
- Evaluation of novel add-on treatments to optimize COPD exacerbation prevention
- Clinical assessment of dry powder inhaler formulations and long-term efficacy studies
The practice actively participates in multi-center trials examining exacerbation reduction strategies in COPD patients already receiving maintenance therapy. Their research capabilities include comprehensive evaluation of ICS, LABA, and LAMA combination therapies, with particular focus on identifying optimal treatment regimens for patients with severe respiratory disease. The integration of clinical practice with sleep medicine allows for holistic patient care and specialized research in respiratory conditions affecting sleep quality.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumologische Praxis und Schlaflabor Lutz Volgmann und Kollegen
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tanimilast (CHF6001) as an Add-On to Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis | Chiesi Farmaceutici S.p.A. | Phase III | Not Recruiting | Jun 2021 | Jun 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tanimilast | 2 | Unknown | 2021-06-16 | 2021-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.